I. Thibault

发表

Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score.

P. Brown, M. Fehlings, L. Rhines, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.

M. Fehlings, A. Sahgal, G. Masucci, 2014, Journal of neurosurgery. Spine.

Magnetic resonance imaging assessment of spinal cord and cauda equina motion in supine patients with spinal metastases planned for spine stereotactic body radiation therapy.

Lijun Ma, M. Fehlings, D. Létourneau, 2015, International journal of radiation oncology, biology, physics.

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.

M. Fehlings, D. Létourneau, B. Cho, 2015, International Journal of Radiation Oncology, Biology, Physics.

Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study

Liying Zhang, M. Fehlings, A. Sahgal, 2015, Supportive Care in Cancer.

Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy.

M. Fehlings, D. Létourneau, A. Yee, 2013, Neuro-oncology.

The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma

P. Cheung, G. Bjarnason, I. Thibault, 2014, Current opinion in supportive and palliative care.

Quality of life changes after stereotactic ablative radiotherapy for liver metastases: A prospective cohort analysis.

Hans T. Chung, Kelvin K. W. Chan, G. Rodrigues, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

58: Acute Quality of Life Changes after Stereotactic Ablative Radiotherapy for Liver Metastasis: A Prospective Cohort Analysis

Hans T. Chung, Kelvin K. W. Chan, G. Rodrigues, 2016 .

Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for liver stereotactic ablative body radiotherapy

Hans T. Chung, W. Chu, R. Korol, 2016, Journal of Radiation Oncology.

Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.

I. Poon, H. Soliman, P. Cheung, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation.

M. Fehlings, D. Létourneau, A. Yee, 2016, Journal of neurosurgery. Spine.

Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.

M. Fehlings, K. Ding, M. Brundage, 2021, The Lancet. Oncology.

Monte Carlo dosimetry of high dose rate gynecologic interstitial brachytherapy.

É. Vigneault, F. Verhaegen, L. Beaulieu, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Risk of vertebral compression fracture specific to osteolytic renal cell carcinoma spinal metastases after stereotactic body radiotherapy: A multi-institutional study.

P. Brown, M. Fehlings, L. Rhines, 2015, Journal of radiosurgery and SBRT.

Radiation myelopathy and spinal cord tolerance

Lijun Ma, A. Sahgal, I. Thibault, 2014 .

Volume of Lytic Vertebral Body Metastatic Disease Quantified Using Computed Tomography-Based Image Segmentation Predicts Fracture Risk After Spine Stereotactic Body Radiation Therapy.

Cari M Whyne, Hany Soliman, Arjun Sahgal, 2017, International journal of radiation oncology, biology, physics.

Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.

I. Poon, H. Soliman, P. Cheung, 2017, International journal of radiation oncology, biology, physics.

Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group.

Susan M. Chang, P. Gerszten, M. Bilsky, 2015, The Lancet. Oncology.

CCTG SC.24/TROG 17.06: A Randomized Phase II/III Study Comparing 24Gy in 2 Stereotactic Body Radiotherapy (SBRT) Fractions Versus 20Gy in 5 Conventional Palliative Radiotherapy (CRT) Fractions for Patients with Painful Spinal Metastases.

M. Fehlings, K. Ding, M. Brundage, 2020, International journal of radiation oncology, biology, physics.

Stereotactic body radiotherapy: a new paradigm in the management of spinal metastases.

Lijun Ma, H. Keller, D. Létourneau, 2013, CNS oncology.

Macroglossia due to Systemic Amyloidosis: Is There a Role for Radiotherapy?

I. Vallières, I. Thibault, Isabelle Thibault, 2011, Case Reports in Oncology.

Assessing Functionality and Benefits of Comprehensive Dose Volume Prescriptions: An International, Multi-Institutional, Treatment Planning Study in Spine Stereotactic Body Radiation Therapy.

Lijun Ma, M. Ruschin, A. Sahgal, 2019, Practical radiation oncology.

Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.

É. Vigneault, S. Aubin, M. Lavallee, 2012, Brachytherapy.

Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.

I. Poon, H. Soliman, P. Cheung, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Management of Bartholin's gland carcinoma using high-dose-rate interstitial brachytherapy boost.

É. Vigneault, S. Aubin, M. Lavallee, 2013, Brachytherapy.

A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.

I. Poon, G. Rodrigues, D. Palma, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.